Dean W Felsher

9PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersRespiratory diseasesMolecular targetsBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 08, 2025
Lactobacillus acidophilus potentiates oncolytic virotherapy through modulating gut microbiota homeostasis in hepatocellular carcinoma.

Jiayu Zhang, Jinneng Yang, Jinyan Luo

|Sep 20, 2024
Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual disease.

Lea Lemaitre, Nia Adeniji, Akanksha Suresh

|Feb 01, 2024
Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma.

Anja Deutzmann, Delaney K Sullivan, Renumathy Dhanasekaran

|Dec 16, 2022
MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages.

Renumathy Dhanasekaran, Aida S Hansen, Jangho Park

|Oct 07, 2022
MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changes.

Delaney K Sullivan, Anja Deutzmann, Josiah Yarbrough

|Apr 22, 2022
Azapodophyllotoxin Causes Lymphoma and Kidney Cancer Regression by Disrupting Tubulin and Monoglycerols.

Arvin M Gouw, Vineet Kumar, Angel Resendez

Pageof 2

Frequent Collaborators

4 joint publications

Renumathy Dhanasekaran

3 joint publications

Anja Deutzmann

2 joint publications

Lea Lemaitre

2 joint publications

Nia Adeniji